Position in ARQT
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$6,818,065
+$5,629,228 QoQ
Shares Held
260,033
+415.3% QoQ
Ownership
0.207%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#62
of 271 holders
Holding Since
Dec 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Derivatives in ARQT
reported options exposure · as of Jun 30, 2026CallValue
$36,708
CallShares
1,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. ARQT ranks #14 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in ARQT
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,818,065 | 260,033 | Shares | Sole | 2026-08-03 | |
| 2026-06-30 | $36,708 | 1,400 | Call | Sole | 2026-08-03 | |
| 2026-03-31 | $65,968 | 2,800 | Put | Sole | 2026-05-13 | |
| 2026-03-31 | $32,984 | 1,400 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $1,188,837 | 50,460 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,161,600 | 40,000 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $4,896,260 | 168,604 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $182,952 | 6,300 | Put | Sole | 2026-02-13 | |
| 2025-09-30 | $569,270 | 30,200 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $390,232 | 20,702 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $94,250 | 5,000 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $349,504 | 24,929 | Shares | Sole | 2025-08-13 | |
| 2025-06-30 | $259,370 | 18,500 | Put | Sole | 2025-08-13 | |
| 2025-06-30 | $451,444 | 32,200 | Call | Sole | 2025-08-13 | |
| 2025-03-31 | $11,245 | 719 | Shares | Sole | 2025-05-14 | |
| 2025-03-31 | $281,520 | 18,000 | Call | Sole | 2025-05-14 | |
| 2023-12-31 | $1,045,228 | 323,600 | Shares | Sole | 2024-02-14 | |
| 2022-03-31 | $1,455,150 | 75,553 | Shares | Sole | 2022-05-27 | |
| 2021-12-31 | $1,730,130 | 83,420 | Shares | Sole | 2022-05-27 | |
| No filing history on record for this holder in this stock. | ||||||